News

Medically reviewed by Femi Aremu, PharmD Ozempic and Wegovy are both glucagon-like peptide-1 (GLP-1) receptor agonists and contain the active ingredient semaglutide. They share many similarities ...
Medically reviewed by Lindsay Cook, PharmDMedically reviewed by Lindsay Cook, PharmD When comparing Rybelsus vs. Ozempic, you may be aware of their similarities. As two type 2 diabetes medications ...
Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic ...
Novo Nordisk today presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic® (semaglutide) injection 1 mg in adults with type 2 diabetes and early-stage ...
Get the latest and most updated news, videos, and photo galleries about Ozempic ...
Ozempic and other game-changing weight loss drugs are popular for a reason — but, nutrition experts say, don't forget the simple foods that were out there controlling appetites first.
Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic® to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and ...
Glucagon-like-peptide-1 agonists like Ozempic have become extremely popular for weight loss. Here are some of the side effects you should know about.
Jab for joy? A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have “an antidepressant effect,” suggesting that… ...
From restaurants to package makers, companies work to calm investors’ GLP-1 jitters. With Eli Lilly’s Zepbound set to enter the fray, companies are flooded with questions about the effect of ...
Among the findings, the report published Monday highlights the impact of Ozempic, other GLP-1 drugs and hormones used in gender-affirming care and lays out sex- and gender-specific risks of stroke.
Ozempic® is now indicated to reduce the risk of kidney disease worsening, kidney failure, and death from cardiovascular disease in adults with type 2 diabetes and chronic kidney disease The ...